Welcome to Peer Review'd, the show where we break down the latest science news and make it make sense. I'm your host, and today we have a packed episode — from a record-breaking surgery to a ticking mystery near our galaxy's black hole. Let's dive in.

We're starting with a story that is nothing short of extraordinary. An eleven-year-old girl at Children's Hospital Colorado just received both a new heart and a new liver in a single sixteen-hour surgery. This was the hospital's first ever combined heart-liver transplant, and it required coordination across twenty-five multidisciplinary teams — dozens of specialists working in sync for the better part of a day. Procedures like this are vanishingly rare, and the fact that it was pulled off successfully is a testament to just how far transplant medicine has come. For this young girl and her family, it's a second chance at life.

Now let's talk cancer — and there's a lot to cover today. First up, scientists may have found what's being called cancer's invisibility switch. An international research team identified a molecular process that helps pancreatic cancer grow while essentially hiding from the immune system. When researchers interfered with this process in the lab, results were promising. Pancreatic cancer is one of the hardest to treat precisely because it's often detected late and evades immune defenses. Finding the mechanism that lets it do that? That's a genuinely significant step.

And there's more on the cancer front. A separate team has caught cancer cells cheating death in a completely unexpected way. We've long known that tumors can develop drug resistance — you treat them, they seem to respond, and then they come back stronger. But scientists still don't fully understand how. This new research uncovers a previously unknown molecular process that cancer cells use to survive treatment. Understanding the escape route is the first step to blocking it.

From cancer to a virus that most of us are already carrying — researchers at Fred Hutch Cancer Center have made a significant advance against the Epstein-Barr virus. If you haven't heard of it, EBV infects roughly ninety-five percent of people worldwide. Most of the time it stays dormant, but it's been linked to certain cancers, neurodegenerative diseases, and other long-term health issues. This new work brings scientists closer to neutralizing it, which could have enormous downstream benefits for global health.

Staying in the medical world — there's a new reason to pay attention to your Ozempic prescription. Researchers at Adelaide University are urging caution about an ingredient called SNAC — salcaprozate sodium — which is used in the oral tablet form of semaglutide to help the drug get absorbed through the gut. An animal study suggests SNAC may have effects beyond just helping the medication along. This is early-stage research, but it's a reminder that the full picture of how these blockbuster weight-loss drugs work — and what else they do — is still being written.

Now for some genuinely exciting early detection news. Scientists at Chalmers University of Technology in Sweden have found biological markers for Parkinson's disease that appear in the blood right at the very beginning of the disease — before significant brain damage has occurred. The catch is that these markers are only detectable during a brief window. If researchers can figure out how to screen for them reliably, it could open a door to earlier intervention. Meanwhile, a study out of the University of British Columbia suggests that multiple sclerosis may actually begin affecting the body more than a decade before symptoms appear. That rewrites the entire timeline of the disease and could fundamentally change how we think about diagnosis and treatment.

On the genetics front, researchers have mapped the risk of a condition called hemochromatosis — sometimes called the Celtic curse — across the UK and Ireland for the first time. This is an iron overload disorder, and hotspots were found in northwest Ireland and the Outer Hebrides, where as many as one in fifty-four people may carry the high-risk gene variant. Left untreated over decades, it can lead to liver cancer and arthritis — but if caught early, it's very manageable. This kind of population-level genetic mapping is exactly the tool needed to get ahead of it.

Here's a fascinating one from high-altitude biology. Scientists have finally figured out why living at high altitude seems to protect against diabetes. When oxygen levels drop, red blood cells switch into a different metabolic mode and absorb much more glucose from the blood. This both helps the body cope with thin air and lowers blood sugar. Researchers were then able to recreate this effect with a drug — and it reversed diabetes in mice. That's a remarkable mechanism hiding in plain sight, literally above the clouds.

Let's shift gears to physics. Cell membranes — the flexible outer layers of our cells — have long puzzled scientists because their behavior seemed inconsistent with existing models. Now researchers say they've cracked it. A long-standing mystery about how membranes behave under various conditions has apparently been resolved, which could have ripple effects across biology and medicine.

In fusion energy, a persistent puzzle has been solved. Inside tokamak reactors — those donut-shaped devices designed to contain superheated plasma — there's been a frustrating asymmetry in how exhaust particles land on the reactor walls. New simulations show that the rotation of the plasma core, combined with something called cross-field drifts, determines where those particles go. Understanding this could help engineers design more efficient and durable fusion reactors.

And artificial intelligence is making waves in plasma physics too. Researchers at Emory University used machine learning to study what's called a many-body system — essentially a large collection of interacting particles — and uncovered unexpected features driven by non-reciprocal forces. The study was published in PNAS, and it suggests AI can surface physics that traditional approaches might miss entirely.

Now for one of the most intriguing stories of the week — something is ticking near the center of our galaxy. Scientists at Columbia University, working with the Breakthrough Listen initiative, have detected signals consistent with a pulsar — a rapidly spinning neutron star — located near the Milky Way's supermassive black hole. Pulsars are essentially cosmic clocks, emitting incredibly regular pulses of radiation. Having one near a supermassive black hole is a dream scenario for physicists because it could let us test the extremes of gravity and spacetime like never before. We'll be watching this one closely.

And finally, great white sharks. A well-known story in marine biology has been that killer whale attacks drove great white sharks away from a key aggregation site off South Africa. It was a dramatic, clean narrative. But long-term tracking data now suggests the reality is far more nuanced. Longer disappearances can't be pinned on orca encounters alone — there are other factors at play that researchers are still working to understand. Science, as always, resists simple stories.

And speaking of things that resist simple explanations — possibly the holy grail of quantum computing may have just been spotted. Scientists believe they've identified a triplet superconductor — a material called NbRe — that can transmit both electricity and electron spin with zero resistance. If verified, this could dramatically stabilize quantum computers and slash their energy consumption. It's early days, but the implications for next-generation computing and spintronic technology are enormous.

That's a wrap on today's episode of Peer Review'd. From surgeries that redefine what's possible to cosmic clocks ticking at the edge of a black hole — science never disappoints. Thanks for listening, stay curious, and we'll see you next time.